37 results on '"Zago, Giulia"'
Search Results
2. New targeted treatments for non-small-cell lung cancer – role of nivolumab
3. Mineralogical clustering of the structural mortars from the Sarno Baths, Pompeii: A tool to interpret construction techniques and relative chronologies
4. Publisher Correction: Localization of RalB signaling at endomembrane compartments and its modulation by autophagy
5. Localization of RalB signaling at endomembrane compartments and its modulation by autophagy
6. WNK1 enforces macrophage lineage fidelity
7. A microbiota-derived metabolite instructs peripheral efferocytosis
8. Autophagy Is Polarized toward Cell Front during Migration and Spatially Perturbed by Oncogenic Ras
9. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
10. Immunometabolism of Tissue-Resident Macrophages – An Appraisal of the Current Knowledge and Cutting-Edge Methods and Technologies
11. 524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine
12. Prevalence and evolution of renal cysts in patients treated with Crizotinib in our centre
13. Neoplastic Pericardial Effusion: A Monocentric Retrospective Study
14. RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
15. Author response: RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
16. Monitoring advanced non-small cell lung cancer (NSCLC) through plasma genotyping during systemic treatment: KRAS-mutated (m) cohort results.
17. Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
18. New targeted treatments for non-small-cell lung cancer – role of nivolumab
19. A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration
20. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists
21. Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
22. P3.01-017 Primary Lung Adenocarcinomas with Enteric Differentiation: A Retrospective Analysis
23. OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies
24. A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration.
25. New targeted treatments for non-small-cell lung cancer – role of nivolumab
26. Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
27. New targeted treatments for non-small-cell lung cancer – role of nivolumab
28. Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
29. Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
30. Direct interaction between Exocyst and Wave complexes promotes cell protrusions and motility
31. Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature
32. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers
33. FDG Avidity at PET/CT During Adjuvant Hormonal Therapy in Patients With Breast Cancer
34. Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer
35. Tim-4 + cavity-resident macrophages impair anti-tumor CD8 + T cell immunity.
36. New targeted treatments for non-small-cell lung cancer - role of nivolumab.
37. Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.